Second Sight Medical (NSDQ:EYES) said today it won reimbursement coverage for its Argus II epiretinal prosthesis from the German Institute for the Hospital Renumeration System, covering 15 hospitals in the group’s NUB1 innovation program. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which […]
second-sight-medical
Second Sight Medical wins U.K. reimbursement nod for Argus II ‘bionic eye’
Second Sight Medical (NSDQ:EYES) said today that the U.K.’s National Health Service granted reimbursement for the company’s Argus II retinal prosthesis system for blind patients with retinitis pigmentosa. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which allows for the perception […]
Second Sight wins CMS reimbursement codes for Argus II ‘bionic eye’
Second Sight Medical (NSDQ:EYES) said today it won reimbursement coverage from the Centers for Medicare & Medicaid Services for procedures using its Argus II retinal prosthesis system designed to restore some vision to blind patients. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which […]
Second Sight reveals 1st implant of Orion I visual cortical stimulator
Second Sight Medical (NSDQ:EYES) said today the 1st patient was implanted with its Orion 1 visual cortical prosthesis device designed to restore vision to blind patients. The procedure was performed as part of a proof-of-concept trial at UCLA. The trial looks to show initial safety and feasibility for human visual cortex stimulation, Sylmar, Calif.-based Second Sight said. […]
Second Sight reels in $19m from oversubscribed rights offering
Second Sight Medical (NSDQ:EYES) said today it raised $19.8 million from an oversubscribed round of rights offering to shareholders of record, with funds slated to support a post-market study of its Argus II retinal prosthesis system. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical […]
GI Dynamics taps medtech vet Schorer for CEO | Personnel Moves March 25, 2016
GI Dynamics taps medtech vet Schorer for CEO Troubled GI Dynamics (ASX:GID) said this week that it named a veteran medical device executive, Scott Schorer, to be its new president & CEO effective immediately. Schorer spent the last 6 years as a consultant, advising and helping run companies including stealthy Auris Robotics and Neograft Technologies, and […]
RIP medical device pioneer Alfred Mann | Personnel Moves
Alfred Mann, a medical device entrepreneur who helped develop several groundbreaking technologies, died yesterday at age 90, shortly after stepping down from a pair of companies he founded. Mann founded 17 companies over his 70-year career, in industries ranging from aerospace to medtech, according to the L.A. Times. After Johns Hopkins University researchers in 1969 […]
Second Sight touts publication of 3-year Argus II study
Second Sight Medical (NSDQ:EYES) said today that the results from the 3-year study of its Argus II Retinal Prosthesis System were published in the Austrian journal Clinical and Experimental Optometry. The study used functional low-vision observer rated assessments, an instrument specifically developed for retinal prosthesis patients with severe loss of vision or blindness, to assess […]
McGuire to take reins at Second Sight, Greenberg heads board | Personnel Moves
Second Sight Medical‘s (NSDQ:EYES) newly appointed CEO Will McGuire is set to take the reins starting August 18, the company said. Announced in June, former CEO Dr. Robert Greenberg will become chairman of the board at Second Sight, replacing Alfred Mann who will become chairman emeritus, according to the Sylmar, Calif.-based ‘bionic eye’-developing company. “Will […]
Zimmer & Biomet shift personnel after acquisition| Personnel Moves
Zimmer (NYSE:ZMH), who acquired Biomet in a deal that closed this month, announced a series of personnel shifts upon the closure of the merger. Zimmer CFO and senior veep James Crines has stepped down from his position to retire, effective August 3, to be replaced by former CFO and senior veep of BiometDaniel Florin, the company said. […]
Second Sight touts 3-year Argus II retinal prosthesis data
Second Sight Medical (NSDQ:EYES) said data from a 3-year study of its Argus II retinal prosthesis system show positive results in previously blind patients. The study, published in Ophthalmology yesterday, examined 30 patients implanted with the Argus II, designed to restore partial vision by stimulating viable retinal cells in patients with severe to profound retinitis pigmentosa, […]